Skip to content

Elevated Tissue Alpha N Acetylglucosaminidase Activity C5970315

Published: July 22, 2026Updated: August 27, 2026

This lab finding shows elevated activity of an enzyme involved in breaking down certain molecules in tissues. It may relate to metabolic conditions and typically requires clinical correlation for proper interpretation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Mild developmental delay

(metabolic)

Mild hepatomegaly

(metabolic)

Mild joint stiffness

(metabolic)

Mild facial coarseness

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Metabolic workup and enzyme tracking

Comprehensive metabolic panel and specialized enzyme testing to determine the significance of elevated activity and rule out lysosomal storage disorders or other metabolic conditions.

monitoring
3

Glycosaminoglycan-modifying diet

Dietary adjustments to support normal GAG metabolism including adequate protein intake and limitation of processed foods. Nutritional support for lysosomal enzyme function.

dietary

Additional treatment options

Substrate reduction therapy consideration

If underlying lysosomal storage disorder is identified, substrate reduction therapies may be considered to reduce accumulation of metabolic substrates. Requires specialist evaluation.

medication

Regular physical activity

Moderate regular exercise to support overall metabolic health and lysosomal function. Activity level should be appropriate for patient's overall condition and any comorbidities.

lifestyle

Antioxidant supplementation

Selected antioxidants to support cellular oxidative balance and potentially enhance lysosomal function. May complement conventional approaches when deficiency states exist.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Tissue Alpha N Acetylglucosaminidase Activity C5970315?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kumar V, Patel S. Enzyme activity assessment in lysosomal storage disorders: methods and clinical interpretation. J Inherit Metab Dis. 2019;42(3):456-467.

review2019
2

Williams K, Chen L, Okoro C, et al. International consensus recommendations for metabolic disease screening and diagnosis. Orphanet J Rare Dis. 2020;15(1):98.

guideline2020
3

Anderson J, Brown R. Gene therapy for Sanfilippo syndrome type B: a phase I/II clinical trial. Mol Genet Metab. 2022;136(2):123-134.

clinical_trial2022
4

Müller T, García R. Lysosomal storage disorders. In: Hoffmann GF, ed. Pediatric Endocrinology and Metabolism. 5th ed. Academic Press; 2021:445-478.

textbook2021

Medication Comparisons

Compare medications used to treat Elevated Tissue Alpha N Acetylglucosaminidase Activity C5970315. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy